Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oil-Dri Corporation of America is a leading global manufacturer and marketer of sorbent mineral products for consumer, industrial, and agricultural markets. The company's Life Sciences segment, primarily operating through its Amlan International division, focuses on animal health and nutrition by providing mineral-based feed additives for livestock. These products utilize proprietary mineral technology to improve gut health, bind harmful mycotoxins, and neutralize enteric pathogens, offering an alternative to antibiotic growth promoters. Beyond animal health, Oil-Dri produces crop protection carriers, cat litter, and purification aids for various fluids. The company is vertically integrated, owning and operating mineral reserves and manufacturing facilities across North America. It is publicly traded on the New York Stock Exchange under the symbol ODC.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oil-Dri Corporation of America.